Impatto Emodinamico Dell'Anestesia Subaracnoidea Titrata Versus Tecnica Single-shot Nei Pazienti Sottoposti ad Artroprotesi d'Anca. RCT
NCT ID: NCT05868642
Last Updated: 2023-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
82 participants
INTERVENTIONAL
2018-06-25
2020-06-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
C2-C4 Compartment Block Versus Block of Costagliola, in TEAC
NCT03409068
Comparison of Different Analgesic Nerve Blocks in Total Knee Replacement Surgery
NCT06422585
Conventional Spinal Anaesthesia Versus Fractional Spinal Anaesthesia on Hemodynamics
NCT06583213
Circumferential Spread of Anesthetic and Success in Sciatic Nerve Blockade
NCT00802581
Ultrasound Guided Intermediate Cervical Plexus Block and Additional Perivascular Local Anesthetic Infiltration
NCT02336958
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
T group
Subaracnhoid block levobupivacaine 0.5%, 10 mg (2 ml) via subarachnoid injection plus 1mg for each metameric level needed to achieve the T10 level sensory block (evaluation with pinprick test at 10 minute after the firts injection and at 4 minute from the second injection)
subarachnoid block
subarachnoid block with levobupivacaine at different dosage for pation undergoing total hip arthroplasty
S group
levobupivacaine 0.5%, 15 mg (3 ml) via subarachnoid injection
subarachnoid block
subarachnoid block with levobupivacaine at different dosage for pation undergoing total hip arthroplasty
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
subarachnoid block
subarachnoid block with levobupivacaine at different dosage for pation undergoing total hip arthroplasty
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA 1-3
* undergoing total hip arthroplasty
* no controindications to subaracnhoid block
* able to understand and sign a written informed consensus
* METs \> o = 4
Exclusion Criteria
65 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istituto Ortopedico Rizzoli
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
battista borghi, professor
Role: PRINCIPAL_INVESTIGATOR
isituto ortopedico rizzoli
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istituto Ortopedico Rizzoli
Bologna, BO, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0000440
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.